Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 26.23
- Piotroski Score 3.00
- Grade Buy
- Symbol (BMR)
- Company Beamr Imaging Ltd.
- Price $3.08
- Changes Percentage (5.12%)
- Change $0.15
- Day Low $2.92
- Day High $3.10
- Year High $34.94
Beamr Imaging Ltd. provides video encoding, transcoding, and optimization solutions in the United States, Israel, and internationally. The company offers a suite of video compression software encoder solutions, including Beamr 4, Beamr 4X content adaptive, Beamr 5, and Beamr 5X content adaptive encoders; Beamr JPEGmini photo optimization software solutions for reducing joint photographic experts group file sizes; and Beamr Silicon IP block, a hardware solution for integration into dedicated video encoding application-specific integrated circuits, graphics processing units, and application processors. It serves tier one over-the-top platforms, content distributors, video streaming platforms, and Hollywood studios. The company was formerly known as I.C.V.T Ltd. and changed its name to Beamr Imaging Ltd. in January 2015. The company was incorporated in 2009 and is headquartered in Herzliya, Israel.
- Last Earnings 09/16/2015
- Ex-Dividend for 5/16 Dividend 09/28/2015
- Dividend Payable 10/15/2015
- Today N/A
- Next Earnings (Estimated) 04/22/2024
- Fiscal Year End N/A
- Average Stock Price Target $0.00
- High Stock Price Target $0.00
- Low Stock Price Target $0.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$0.09
- Trailing P/E Ratio -48
- Forward P/E Ratio -48
- P/E Growth -48
- Net Income $-695,000
Income Statement
Quarterly
Annual
Latest News of BMR
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Beyond the Balance Sheet: What SWOT Reveals About Biomarin Pharmaceutical Inc (BMRN)
Biomarin Pharmaceutical Inc shows financial growth in its 10-Q report, with a focus on rare-disease therapies. Despite revenue increase, rising operating expenses require careful management. Market le...
By Yahoo! Finance | 1 week ago -
Biomarin Pharmaceutical Inc (BMRN) Q3 2024 Earnings Call Highlights: Record Revenue Growth and ...
BMN 333 aims to enhance CNP's half-life for improved effects in skeletal disorders. The trial length and expansion into other indications are flexible based on data. Factors impacting financials inclu...
By Yahoo! Finance | 1 week ago -
Bank of Marin Bancorp (BMRC) Q3 2024 Earnings Call Highlights: Strategic Gains Amidst Market ...
Tani Girton, CFO, expects a positive impact on the net interest margin from rate cuts. Timothy Myers, President and CEO, sees comfort in resuming share buybacks due to strong metrics. Girton details e...
By Yahoo! Finance | 1 week ago
